The Distribution and ‘In Vivo’ Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Two haemoglobin-binding proteins, HmbR and HpuAB, contribute to iron acquisition by Neisseria meningitidis. These receptors are subject to high frequency, reversible switches in gene expression--phase variation (PV)--due to mutations in homopolymeric (poly-G) repeats present in the open reading frame. The distribution and PV state of these receptors was assessed for a representative collection of isolates from invasive meningococcal disease patients of England, Wales and Northern Ireland. Most of the major clonal complexes had only the HmbR receptor whilst the recently expanding ST-275-centred cluster of the ST-269 clonal complex had both receptors. At least one of the receptors was in an 'ON' configuration in 76.3% of the isolates, a finding that was largely consistent with phenotypic analyses. As PV status may change during isolation and culture of meningococci, a PCR-based protocol was utilised to confirm the expression status of the receptors within contemporaneously acquired clinical specimens (blood/cerebrospinal fluid) from the respective patients. The expression state was confirmed for all isolate/specimen pairs with <15 tract repeats indicating that the PV status of these receptors is stable during isolation. This study therefore establishes a protocol for determining in vivo PV status to aid in determining the contributions of phase variable genes to invasive meningococcal disease. Furthermore, the results of the study support a putative but non-essential role of the meningococcal haemoglobin receptors as virulence factors whilst further highlighting their vaccine candidacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N. meningitidis serotype B isolates associated with disease also exhibit “on” phase variation of HmbR”
From Heme Synthesis and Acquisition in Bacterial Pathogens (2016) · cites this paper as [208]
In the citing paper
“correlating virulence with the expression of HmbR [208].”
From Heme Synthesis and Acquisition in Bacterial Pathogens (2016) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833 · cited 3×
“Tauseef et al. [16] utilised 90 IMD strains from the strain panel used to evaluate multilocus sequence typing (MLST) [23].”
MethodSelf-citationSierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446 · cited 1×
“The polysaccharide of serogroup B meningococci (MenB), a leading cause of IMD in industrialized nations, is poorly immunogenic in humans [4].”
BackgroundThe Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421 · cited 1×
“Neisseria meningitidis (the meningococcus) is a commensal of the human nasopharynx with an overall prevalence of approximately 10% [1].”
BackgroundSerruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404 · cited 1×
“Such a need for multiple antigens or antigenic variants has been demonstrated for other subcapsular antigens, including those of the recently licensed 4CMenB vaccine [34] or Pfizer’s investigational bivalent recombinant fHbp vaccine [8].”
BackgroundMadico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.501 · Cited by 390 · cited 1×
“Other MenB vaccines have not focused on potential redundancy-mediated escape in this way [27,28].”
BackgroundVogel, U., Taha, M.-K., Vazquez, J. A., Findlow, J., Claus, H., Stefanelli, P., Caugant, D. A., Kriz, P., Abad, R., Bambini, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70006-9 · Cited by 285 · cited 1×
“Universal vaccine coverage of MenB is, however, yet to be achieved [9].”
BackgroundSelf-citationGray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221 · cited 1×
“35 [20] were excluded from the study in order to maximise the ability to detect the Hb receptor genes.”
BackgroundSelf-citationJiang, H.-Q., Hoiseth, S. K., Harris, S. L., McNeil, L. K., Zhu, D., Tan, C., Scott, A. A., Alexander, K., Mason, K., Miller, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.083 · Cited by 198 · cited 1×
“Such a need for multiple antigens or antigenic variants has been demonstrated for other subcapsular antigens, including those of the recently licensed 4CMenB vaccine [34] or Pfizer’s investigational bivalent recombinant fHbp vaccine [8].”
BackgroundThe Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence
Stojijkovic, I., Hwa, V., de Saint Martin, L., O'Gaora, P., Nassif, X., Heffron, F., & So, M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02266.x · Cited by 188 · cited 1×
“The TonB dependent HmbR and HpuAB systems are each able to bind Hb, whilst the latter also binds the Hb-haptoglobin complex [12,13].”
Background
Research works printed but not linked: 1
- Lucidarme J (2012) Ph.D. thesis. Potential coverage of an investigational, multicomponent, meningococcal vaccine with a focus on the ST-269 clonal complex. University of Manchester, Manchester, United Kingdom.
Cited by
Heme Synthesis and Acquisition in Bacterial Pathogens
Choby, J. E., & Skaar, E. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.018 · Cited by 343
Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis
Caugant, D. A., & Brynildsrud, O. B. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0282-6 · Cited by 134
Phase-variable bacterial loci: how bacteria gamble to maximise fitness in changing environments
Phillips, Z. N., Tram, G., Seib, K. L., & Atack, J. M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180633 · Cited by 104
An Overview of Neisseria meningitidis
Hollingshead, S., & Tang, C. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9202-7_1 · Cited by 59
Subversion of nutritional immunity by the pathogenic Neisseriae
Cornelissen, C. N. (2018) · Pathogens and Disease · doi:10.1093/femspd/ftx112 · Cited by 49
Metadata
- Authors
- Lucidarme, J., Findlow, J., Chan, H., Feavers, I. M., Gray, S. J., Kaczmarski, E. B., Parkhill, J., Bai, X., Borrow, R., & Bayliss, C. D.
- Affiliations
- Public Health England (GB)
- National Institute for Biological Standards and Control (GB)
- Wellcome Sanger Institute (GB)
- University of Leicester (GB)
- Corresponding author
- Lucidarme, Jay
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-30
- Volume
- 8
- Issue
- 9
- Pages
- e76932
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3786947
- OpenAlex
- W2028189542
- Cited by
- 21
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Meningitis Research Foundation
- University of Oxford
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Keywords
- Neisseria meningitidis serogroup B, invasive meningococcal disease, phase variation, iron acquisition, virulence factors
- MeSH terms
- Bacterial Outer Membrane Proteins, Bacterial Proteins, Genotype, United Kingdom, Hemoglobins, Humans, Iron, Meningitis, Meningococcal, Phenotype, Receptors, Cell Surface, Gene Expression Regulation, Bacterial, Sequence Analysis, DNA, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.